Acne vulgaris
Conditions
Interventions
Group A: The treatment with medicine for external use (Adapalen and Nadifloxacine or Clindamycine) for 12 weeks
Group B: The treatment with medicine for external use (Adapalen and Nadifloxacine or
Sponsors
Faculty of Medicine Fukuoka University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who have inflammatory of acne lesions on their faces 2) Patients for whom oral administration was possible 3) Patients who agreed with their written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with serious complications (liver, kidney, heart, blood, or metabolic disorders) 2) Women who are pregnant,might be pregnamt or lactating or planning a pregnancy 3) Patients who received drugs prohibited for concomitant use within 1 week before the registration of this study 4) Patients who participated in clinical trial within 1 month before the registration of this study 5) Patients taking or planning chemical treatment or laser treatment in this study period 6) Patients with history of hypersensitivity to traditional Japanese medicine 7) Patients considered inappropriate by the study investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| *The decrement of inflammatory of acne lesions *The decrement of non-inflammatory of acne lesions *Skindex-16 *Patients satisfaction(Visual analog scale) | — |
Countries
Japan
Contacts
Public ContactShinichi Imafuku
Faculty of Medicine Fukuoka University Department of Dermatology
Outcome results
None listed